Nick Wu

Nicholas (Nick) Wu, Ph.D., is a Senior Healthcare Analyst and Portfolio Manager at ClearBridge Investments, where he has been a key team member since 2007. Based in San Francisco, Dr. Wu leads research and investment management across the healthcare sector, focusing on public equities related to pharmaceuticals, biotechnology, medical devices, and healthcare services. His primary responsibilities include identifying industry trends, evaluating company strategies, and generating actionable investment ideas within the healthcare space.

Earlier in his career, Dr. Wu served as an Equity Research Analyst at Bear Stearns, where he covered similar healthcare sectors, and as an Associate Consultant at Plan A Consulting, honing his analytical and strategic skills. Over his more than two decades in the investment industry, he has earned recognition for his deep sector expertise and active involvement in thematic research, such as innovations in diabetes management, obesity therapies, and clinical diagnostics.

Dr. Wu holds a Doctor of Philosophy in Chemistry from Stanford University and a Bachelor of Arts in Chemistry from Washington University, equipping him with a strong scientific foundation for fundamental industry analysis. He is known for integrating environmental, social, and governance (ESG) analysis into investment processes and for contributing to ClearBridge’s thought leadership on healthcare industry innovation and long-term sustainability.